Divalproex sodium vs. valproic acid: Drug utilization patterns, persistence rates and predictors of hospitalization among VA patients diagnosed with bipolar disorder

Journal of Clinical Pharmacy and Therapeutics

Volumn 32, Issue 6, 2007, Pages 625-632

  Iqbal, S U ^a   Cunningham, F ^b   Lee, A ^b,c,d   Wang, S ^b   Hamed, A ^a   Miller, D R ^b   Ren, X ^b   Kazis, L ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Sungkyunkwan University   (South Korea)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Bipolar disorder; Divalproex sodium; Hospitalization; Persistence; Valproic acid; Veterans Affairs

Indexed keywords

VALPROATE SEMISODIUM; VALPROIC ACID;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; COMORBIDITY; CONTROLLED STUDY; DRUG UTILIZATION; FEMALE; HEALTH CARE SYSTEM; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PHARMACY; PRESCRIPTION; PROGNOSIS; RISK ASSESSMENT; VETERAN;

ANTIMANIC AGENTS; BIPOLAR DISORDER; COHORT STUDIES; DRUG UTILIZATION; DRUGS, GENERIC; HOSPITALIZATION; HUMANS; RETROSPECTIVE STUDIES; VALPROIC ACID;

EID: 36248977531     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2007.00876.x     Document Type: Article

References (14)

1. http://www.nimh.nih.gov/publicat/bipolar.cfm (accessed 20 May 2005).
2. Keller MB, Baker LA (1991) Bipolar disorder: epidemiology, course, diagnosis, and treatment. Bulletin of the Menninger Clinic, 55, 172 181.
3. The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder (2000) A post graduate medicine special report. Available at: http://www.psychguides.com (accessed 20 May 2005).
4. Macritchie KA, Geddes JR, Scott J, Haslam DR, Goodwin GM (2001) Valproic acid, valproate and divalproex in the maintenance of bipolar disorder. Cochrane Database of Systematic Reviews, 3, CD003196.
5. Sherwood Brown E, Shellhorn E, Suppes T (1998) Gastrointestinal side-effects after switch to generic valproic acid. Pharmacopsychiatry, 31, 114.
6. Levine J, Chengappa KN, Parepally H (2000) Side effect profile of enteric-coated divalproex sodium versus valproic acid. Journal of Clinical Psychiatry, 61, 680 681.
7. Wilder BJ, Karas BJ, Penry JK, Asconape J (1983) Gastrointestinal tolerance of divalproex sodium. Neurology, 33, 808 811.
8. Sherr JD, Kelly DL (1998) Substitution of immediate-release valproic acid for divalproex sodium for adult psychiatric inpatients. Psychiatric Services, 49, 1355 1357.
9. Schwartz TL, Massa JL, Gupta S, Samarrai SA, Devitt P, Masand PS (2000) Divalproex sodium versus valproic acid in hospital treatment of psychotic disorders. Journal of Clinical Psychiatry, 2, 45 48.
10. Divalproex sodium. [package insert] 1995). Chicago, IL : Abbott Laboratories.
11. Selim AJ, Fincke G, Ren XS et al. (2002 The comorbidity index. In : Davies M, ed. Measuring and managing health care quality, 2nd edn. New York, NY : Aspen Publishers.
12. Zarate CA, Tohen M, Narendran R, Tomassini EC, Mcdonald J, Sederer DM, Madrid AR (1999) The adverse effect profile and efficacy of divalproex sodium compared with valproic acid: a pharmacoepidemiology study. Journal of Clinical Psychiatry, 60, 232 236.
13. Cranor CW, Sawyer WT, Carson SW, Early JJ (1997) Clinical and economic impact of replacing divalproex sodium with valproic acid. American Journal of Health-System Pharmacy, 54, 1716 1722.
14. Wassef AA, Winkler DE, Roache AL et al. (2005) Lower effectiveness of divalproex versus valproic acid in a prospective, quasi-experimental clinical trial involving 9,260 psychiatric admissions. The American Journal of Psychiatry, 162, 330 339.